Quidel Corporation
QDEL, a leading provider of diagnostic testing solutions,
announced today that it has received the CE Mark for its Sofia Strep
A FIA for use with its Sofia Analyzer.
Sofia is the brand name for Quidel's next generation, immunoassay
system. The Sofia Analyzer and Sofia Strep A FIA combine unique
fluorescent chemistry, advanced lateral flow technology, and failure
alert and fail-safe systems to ensure a reliable, objective, rapid
and highly accurate diagnostic result. This press release follows
closely on the recent announcement (October 26th) of the FDA
clearance of the Sofia Analyzer and Sofia Influenza A+B FIA.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in